IRIS
OLIVIERI, Attilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.997
EU - Europa 7.833
AS - Asia 6.204
SA - Sud America 2.201
AF - Africa 399
Continente sconosciuto - Info sul continente non disponibili 56
OC - Oceania 8
AN - Antartide 1
Totale 30.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.790
SG - Singapore 2.012
BR - Brasile 1.829
UA - Ucraina 1.478
CN - Cina 1.114
IT - Italia 995
RU - Federazione Russa 944
IE - Irlanda 940
DE - Germania 862
SE - Svezia 827
HK - Hong Kong 795
TR - Turchia 735
VN - Vietnam 732
DK - Danimarca 599
FI - Finlandia 401
KR - Corea 318
GB - Regno Unito 280
FR - Francia 203
CI - Costa d'Avorio 177
AR - Argentina 163
IN - India 134
CA - Canada 106
MA - Marocco 105
ID - Indonesia 76
MX - Messico 71
NL - Olanda 71
EC - Ecuador 68
JP - Giappone 64
PL - Polonia 57
EU - Europa 54
BD - Bangladesh 52
ZA - Sudafrica 47
AT - Austria 37
CO - Colombia 35
ES - Italia 35
IQ - Iraq 35
PY - Paraguay 34
UZ - Uzbekistan 27
VE - Venezuela 26
BE - Belgio 22
EG - Egitto 21
CL - Cile 19
TN - Tunisia 19
AE - Emirati Arabi Uniti 15
LT - Lituania 14
PE - Perù 14
CZ - Repubblica Ceca 13
PK - Pakistan 12
KZ - Kazakistan 11
JO - Giordania 9
RO - Romania 9
UY - Uruguay 9
SA - Arabia Saudita 8
DZ - Algeria 7
IL - Israele 7
OM - Oman 7
SN - Senegal 7
DO - Repubblica Dominicana 6
KE - Kenya 6
NP - Nepal 6
AL - Albania 5
AU - Australia 5
CR - Costa Rica 5
GR - Grecia 5
IR - Iran 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CH - Svizzera 4
HN - Honduras 4
JM - Giamaica 4
PH - Filippine 4
RS - Serbia 4
BO - Bolivia 3
BZ - Belize 3
GA - Gabon 3
HU - Ungheria 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
PS - Palestinian Territory 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BN - Brunei Darussalam 2
GI - Gibilterra 2
GT - Guatemala 2
KW - Kuwait 2
MD - Moldavia 2
MT - Malta 2
MY - Malesia 2
NR - Nauru 2
PA - Panama 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AQ - Antartide 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
Totale 30.679
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.572
Ashburn 1.284
Singapore 1.124
Chandler 1.023
Dallas 1.003
Fairfield 945
Dublin 935
Boardman 847
Hong Kong 793
Wilmington 525
Houston 403
Woodbridge 364
Lawrence 358
Princeton 358
New York 356
Seattle 353
Des Moines 325
San Mateo 321
The Dalles 284
Ho Chi Minh City 281
Cambridge 257
Ann Arbor 252
Beijing 248
Los Angeles 242
Hefei 228
Moscow 216
Abidjan 177
Hanoi 159
São Paulo 155
San Diego 139
Chicago 136
Munich 125
Centro 104
Buffalo 99
Milan 99
Turin 73
Ancona 72
Redmond 70
London 67
Guangzhou 60
Shanghai 55
Turku 53
Salt Lake City 49
Rio de Janeiro 47
Rome 46
Tokyo 45
Warsaw 43
Helsinki 42
Pune 39
Curitiba 38
Washington 38
Denver 37
Brooklyn 36
Orem 34
Stockholm 34
Columbus 31
Nuremberg 31
Santa Clara 31
Venice 31
Belo Horizonte 30
Da Nang 30
Johannesburg 30
Boston 29
Brasília 29
Wuhan 29
Phoenix 28
Haiphong 27
Pianella 27
Porto 27
Montreal 26
Toronto 26
Atlanta 25
Poplar 25
Campinas 24
Chennai 24
Guayaquil 24
Izmir 24
Marche 24
Elk Grove Village 23
Thái Bình 23
Amsterdam 22
Biên Hòa 22
Frankfurt am Main 22
Tashkent 22
Mexico City 21
San Francisco 21
Norwalk 20
Guarulhos 19
Mumbai 19
Salvador 19
Santo André 19
Tampa 19
Brussels 18
Goiânia 18
Hải Dương 18
Prescot 17
Quito 17
Shenzhen 17
Manchester 16
Porto Alegre 16
Totale 18.128
Salva come PNG Salva come JPEG
Nome #
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 350
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 185
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 184
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 171
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 159
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 155
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 153
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. 152
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 151
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 151
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 151
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 141
Glial-like differentiation potential of human mature adipocytes 141
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 138
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 137
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 136
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 136
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 135
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 132
[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]. 131
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 131
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 131
[Hodgkin's lymphoma and secondary leukemias]. 129
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 128
[Autoimmune thrombocytopenic purpura and circulating immune complexes]. 125
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 125
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 124
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 124
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 124
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 124
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 124
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 123
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 122
Acute promyelocyte leukemia arose from CALR 1 mutated post essential thrombocythemia- myelofibrosis with splanchnic vein thrombosis: A case report 121
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 120
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: A survey from the ALWP of the EBMT 120
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 119
Plasticity of human dedifferentiated adipocytes toward endothelial cells 119
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 119
[Evaluation of the colonization efficiency and in vitro drug sensitivity of the continuous K 562 line]. 118
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 118
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 118
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 118
[Polyneuropathies associated with lymphoplasmacytic dyscrasias: the clinical and instrumental characteristics of a 38-patient case load]. 117
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 116
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 116
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 115
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 115
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 114
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 114
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 114
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 114
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 113
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 113
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 113
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 112
Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 111
Bone marrow adipocytes support haematopoietic stem cell survival 111
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 111
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease 111
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel 109
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 109
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 109
Molecular and functional characterization of human bone marrow adipocytes 109
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 109
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 108
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 108
[Polychemotherapy versus melphalan-prednisone in multiple myeloma]. 106
[Beta 2-microglobulin in lymphoproliferative disorders]. 106
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 106
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell trasplantation 104
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 104
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 104
T Repleted Haploidentical Mismatch Allogeneic Versus Autologous Hematopoietic Stem Cell Transplantation In Adult Patients With Acute Leukemia In Complete Remission (CR): A pair-Matched Analysis From The Acute Leukemia Working Party Of EBMT 103
[Hairy cell leukemia: therapy with lithium carbonate]. 102
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 102
In vivo purging with bortezomib and cyclophosphamide, followed by autologous stem cell transplantation and thalidomide consolidation in elderly patients with multiple myeloma 101
Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 101
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 101
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma 101
Response: Imatinib in lung cGVHD of mild to moderate severity 100
Radioimmunotherapy (Y-90-Zevalin (R)) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study 100
Hematologic reconstitution after PBPC autotransplantation: comparison between programmed-rate freezing and uncontrolled-rate freezing at -80 degrees C 100
A novel homozygous stop-codon mutation in human HFE responsible for nonsense-mediated mRNA decay 100
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 99
History and scientific production of clinica medica and clinica ematologica in ancona 99
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 99
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 98
Allogeneic Stem Cell Transplantation (Allo-SCT) Following a Reduced-Intensity Conditioning (RIC) Regimen in Relapsed Peripheral T-Cell Lymphomas (PTCL): Results at 4 Year of Median Follow-up 98
Patients with chronic extensive GvHD produce high levels of stimulatory auto-antibodies to the PDGF receptor: a new pathophysiological pathway of the disease progression 98
Mobilization policy in multiple myeloma: Minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean 98
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 98
Gastrointestinal Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Multidisciplinary Approach with Early Endoscopic Evaluation 98
Bone Marrow histopathological and molecular changes of small B-cell lymphomas after rituximab therapy: comparison with clinical response and patients autcome 97
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 97
Lenalidomide and low dose dexamethasone for newly diagnosed primary plasma cell leukemia 97
Prevalence of Type 1 Gaucher Disease in Patients with Multiple Myeloma: Updated Interim Analysis of a Prospective, Multicentre, Observational Study 96
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 96
Conditioning Regimens for Frail Patients with Acute Leukemia Undergoing Allogeneic Stem Cell Transplant: How to Strike Gently 96
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 95
Totale 12.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.896
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 167.896
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.152 0 0 0 0 0 267 376 193 445 256 436 179
2021/20222.695 123 692 35 184 18 91 172 220 137 236 206 581
2022/20233.672 442 395 366 231 213 498 9 162 1.019 16 240 81
2023/20242.592 453 64 136 431 439 402 70 58 16 66 59 398
2024/20255.800 644 525 173 61 170 165 753 170 1.205 450 541 943
2025/20267.635 1.004 1.174 1.413 2.113 1.246 685 0 0 0 0 0 0
Totale 31.269